SUMMARY The first medical cure of a corneal infection due to an Acanthamoeba species is reported. The 44-year-old patient developed a suppurative keratitis associated with an epithelial defect, hypopyon, and secondary glaucoma. Acanthamoeba was confirmed as the causative agent four months after presentation when positive cultures were obtained from the cornea and from the conjunctiva. Sensitivity studies of the isolated organism were performed, and the infection was successfully controlled by treatment with a combination of dibromopropamidine and propamidine isethionate ointment and drops and neomycin drops. Keratoplasty was performed 22 months after onset, and no viable acanthamoebae were present in the resected tissue, though possible cyst remnants were identified by immunofluorescent techniques.
Infection of the eye with Acanthamoeba species has been reported many times'-7 and has been associated with a fatal meningoencephalitis.2 These infections are difficult to recognise and treat,' and acanthamoeba is usually considered only after failure of conventional treatment for more common causes of suppurative keratitis. No medical cure has yet been reported, and the outcome of all cases has been very poor, with excisional keratoplasty as the most successful diagnostic and therapeutic measure.
Case report CLINICAL PRESENTATION
The patient was a 44-year-old meat porter, physically very fit and a marathon runner. In April 1979 he was splashed in the right eye with blood from a condemned carcass of meat but did not suffer any direct trauma to the eye. Within a few days the eye became red and sore and a variety of topical medicaments were given by the patient's general practitioner and local ophthalmologist including mydriatics, aureomycin, gentamicin, and neomycin with corticosteroid drops. Because of continuing deterioration the patient was referred to Moorfields Eye Hospital, where in June the findings were of a suppurative keratitis, hypopyon, and secondary glaucoma without any distinctive features. Corneal and conjuncCorrespondence to Mr P Wright, FRCS, Moorfields Eye Hospital, City Road, London ECIV 2PD. tival cultures and smears showed no organisms and no growth in any media but only pus cells and debris. A slow improvement in the signs followed subconjunctival and topical gentamicin, mydriatics, and topical dilute steroids with acetazolamide to control the intraocular pressure. The improvement was not maintained, and on several occasions the hypopyon increased for no obvious reason and then regressed again on continued treatment. This relapsing course continued for several months and in September the corneal epithelium broke down, with increasing stromal suppuration and hypopyon, producing an appearance similar to that seen in a patient subsequently shown to have acanthamoeba infections. Smears continued to show only pus cells and debris with no organisms. But special cultures for acanthamoeba from both cornea and conjunctiva grew Acanthamoeba sp. identified morphologically as A. polyphaga and continued to be positive for some days (Table 1) . Nasal and pharyngeal cultures for acanthamoeba were also taken frequently and were all negative, as were cultures from the unaffected left eye.
CULTURE TECHNIQUE
Petri dish plates were prepared with 1-5% Oxoid L28 agar, allowed to set, and left overnight at room temperature. Aerobacter (Klebsiella) aerogenes was grown in trypticase-soy broth or on nutrient agar, and the bacteria were washed by centrifugation three 778 times in phosphate-buffered saline (PBS). The bacterial pellet was resuspended to give a milky suspension in distilled water and stored (up to three months) at 4°C. Two to three drops were spread on the agar plates, allowed to absorb at 37°C, and the patient's samples were inoculated directly on to the surface of the plates. They were incubated at 37°C in a moist atmosphere for up to three days, and were examined for growth of amoebae by an inverted microscope. Further identification of the amoebae was by examination of trophozoites and cysts in suspension in Page's saline9 under normal light and phase-contrast microscopy. On the basis of the presence of acanthopodia in the slowly moving trophozoite, and a polygonal double walled cyst with characteristic ostioles, the organisms were assigned to the genus Acanthamoeba.
TREATM ENT
On the basis of previous sensitivity results from cases of acanthamoeba infection at Moorfields (discussed later) treatment was begun with drops of propamidine isethionate 0 1% hourly by day and night with dibromopropamidine ointment 0-15% four-hourly. After nine days of treatment the eye became much redder with rapidly worsening lid swelling despite improvement in corneal signs. These changes were attributed to toxicity, and since the sensitivity results for the organism cultured (Table 2) were now available treatment was changed to neomycin drops four-hourly day and night. By October the epithelium had healed, and four-hourly prednisolone drops were added, with steady improvement in the corneal inflammatory signs. The treatment was slowly reduced until the patient was using only neomycin drops four times daily. These were continued for one year, at which time limbal follicles developed with some increased palpebral conjunctival hyperaemia and cellularity but no sign of any skin irritation. All topical therapy was stopped and penetrating keratoplasty proposed, but not performed for a further four months at the patient's request for social reasons. During this period all the limbal and conjunctival signs disappeared, and no topical therapy was given.
An 8 mm penetrating keratoplasty was carried out 22 months after initial presentation. The postoperative treatment included propamidine isethionate drops four times daily in addition to the usual topical steroid and antibiotics employed. The propamidine drops were continued four times daily for two months without any evidence of adverse effect on the corneal graft or the remainder of the eye. After cessation of therapy the graft remained clear for nine months, when a rejection episode developed but was easily controlled with topical steroids. The graft remains (Table 3) . Antibody could not be detected in serum or aqueous humour at the time of keratoplasty. 
Drug sensitivity testing in vitro
The test was carried out as follows. A suspension of 100 000 to 250 000 trophozoites and cysts of acanthamoeba per ml was prepared in PBS. Washed live Aerobacter aerogens organisms grown in broth or on nutrient agar were suspended to an optical density of 6-0 at 650 nm in PBS. Drugs were prepared at a concentration 20 times that desired, also in PBS. 0-1 ml of amoebic and bacterial suspensions was added to 1-7 ml of PBS in sterile, screw-capped 10 ml test tubes, and 0 1 ml of drug solution was added. In control tubes 0 1 ml of PBS was added instead of drug solution. The test was carried out in duplicate. The tubes were incubated at 37°C for 48 hours. Five 0-02 ml samples were examined from mixed suspension from each tube to detect motile amoebae with typical acanthopodia. Where no apparently viable amoebae were found, the medium was centrifuged at 700 g for five minutes, and the sediment was inoculated on to non-nutrient agar plates coated with A. aerogenes and incubated further for 72 hours to detect any viable cysts or trophozoites.
Each experiment therefore gave two results, a minimum inhibitory concentration (MIC) for inhibition of trophozoite growth (MIC.I) and MIC for killing of trophozoites and cysts (MIC.AmC). Tests were initially carried out on an isolate of acanthamoeba from a corneal ulcer which was undergoing treatment at Moorfields Eye Hospital.' Subsequent less extensive tests with the most effective drugs were carried out on new isolates as they were obtained."' Table 4 lists the results of the original wide-ranging drug screen.
Propamidine and dibromopropamidine
Propamidine and dibromopropamidine isethionate have long been available as ocular therapeutic substances as drops and ointment (Brolene, Otamidyl, May and Baker antiseptic cream) and have been used in the treatment of blepharitis and also superficial skin infection such as that complicating burns. The compounds show antibacterial and antifungal properties in addition to the amoebicidal effect reported here. Dibromopropamidine isethionate is soluble 1 in 2 in water, and a 5% solution has pH 5-7. The commercially available preparation is a 0-15% cream (Brolene, May and Baker). It is reported to be active against pyogenic cocci, Staphylococcus aureus, Gram-negative organisms including Escherichia coli, Proteus vulgaris, and some strains of Pseudomonas. Propamidine isethionate is similar but less soluble in water, 1 in 5, and is commercially available as a 0-1% solution (Brolene eye drops). It shows a reduced spectrum of activity, being active against staphylococci and Str. pyogenes but inactive against Pseudomonas, Proteus, and E. coli.
The drops and ointment produced no serious adverse effects, but our experience of local irritation accords with the reported superficial necrosis of granulation tissue seen in some patients after topical application to wounds for more than 10 days. The initial treatment with Brolene was probably overintensive, but subsequent therapy with the drops four times daily was well tolerated for two months, suggesting that any initial intensive treatment period should not be for more than one week and thereafter treatment four times daily or less should suffice. The optimum treatment regimen remains to be determined, but propamidine and dibromopropamidine seem to offer the first effective medical treatment of this challenging group of ocular infections. group.bmj.com on July 6, 2017 -Published by http://bjo.bmj.com/ Downloaded from
